Company Overview and News

0
DoTr targets common station contract award next month

2018-07-19 bworldonline
THE Department of Transportation (DoTr) said the contract for the construction of the Metro Rail Transit (MRT)-Light Rail Transit (LRT) common station project is scheduled to be awarded by August.
FPAFY SMCP1 MPCIY PXMFF SMGBY 0142 SMGBF SMPH SMC2B SMC2A PX FPAFF SMC SMC2D SMC2C MPI MPCFF SMC2F SPHXY SMC2E SPHXF SPHZF PXMFY

0
ETII pursues projects in Visayas

2018-07-13 business.inquirer.net
Ecosystem Technologies International Inc. (ETII), part of the Metro Pacific Water portfolio, is eyeing projects with local governments in the Visayas in preparation for an expansion drive into Southeast Asian and African markets.
SMPH SPHXY AYAAY SPHXF SPHZF SHNG ALI AYAAF

0
Rise; Indonesia, Malaysia extend rally to 5th session

2018-07-13 theedgemarkets
(July 13): Southeast Asian stock markets edged higher on Friday, with Indonesia and Malaysia extending gains to a fifth consecutive session, as worries over U.S.-China trade tensions eased.
SMPH SMIVY SVTMF SPHXY SM SPHXF SPHZF

0
Morales urges every Filipino to take up fight vs graft

2018-07-12 newsinfo.inquirer.net
Two weeks before her retirement on July 26, outgoing Ombudsman Conchita Carpio Morales challenged “every Filipino to take up the cause of anticorruption as a personal crusade.”
SMPH SPHXY SPHXF SPHZF

0
10 Philippine firms in Nikkei’s Asia300 list

2018-07-11 bworldonline
TEN Philippine companies made it to the Nikkei Asian Review’s third annual list of Asia300 Power Performers Ranking, which ranks the most powerful and valuable listed companies in Asia.
JGSMY GTCAP GTCXY JGS CEBUY JBFCF MPCFF SPHXF SPHZF CEB JGSHF UVRBF AYAAF DMC MPCIY AYAAY JBFCY DMCIF UVRBY DMCP SMPH CEBUF MPI SPHXY JFC URC DMCHY ALI

0
Most rise; Singapore rallies from 14-mth low

2018-07-09 theedgemarkets
(July 9): Most Southeast Asian stock markets rose on Monday, with Singapore bouncing back from a 14-month low, as broader Asian shares rallied after a week of losses stemming from worries over a trade war between the United States and China.
TLK SMPH DBSDY D05 DBSDF SPHXY PBCRY SPHXF PETFF SPHZF PBCRF

0
Stocks rally on bargain hunting ahead of data

2018-07-04 bworldonline
LOCAL STOCKS jumped to their fourth straight day of gains on Wednesday as investors continued to search for bargains given the main index’s historically low valuation.
SMPH SMIVY PSKXF SVTMF SPHXY PHSXY SM PSE SPHXF SPHZF

0
Stocks rally as investors hunt for bargains

2018-07-04 bworldonline
Local stocks climbed on Wednesday as investors continued to search for bargains given the main index’s historically low valuation.
SMPH SMIVY PSKXF SVTMF SPHXY PHSXY SM PSE SPHXF SPHZF

16
PSEi rebounds, gains 1.8%

2018-06-29 business.inquirer.net
The benchmark Philippine Stock Exchange index (PSEi) stocks rebounded from recent losses to close just below the 7,200 mark, in what an analyst described as a temporary recovery.
SMPH PSKXF SPHXY AYAAY PHSXY PSE SPHXF SPHZF ALI AYAAF

24
Index slides 1.53%

2018-06-28 business.inquirer.net
The benchmark Philippine Stock Exchange index (PSEi) slid anew yesterday amid mixed sentiments in the region and the decline in Wall Street overnight.
PSKXF BDOUY AYAAY JBFCY AEV BDOUF SMPH BDO JBFCF ABTZY SPHXY JFC PHSXY PSE SPHXF SPHZF ALI AYAAF

6
Indonesian shares slump to one-year low, Philippines resumes fall

2018-06-28 malaymail
SINGAPORE, June 28 — Most South-east Asian stock markets fell today, with the Philippines giving up the previous session's solid gains and Indonesia plunging to a more than one-year low, as simmering US-China trade tensions kept investors off risky bets.
SMPH SPHXY SPHXF SPHZF

10
Philippines snaps 8 sessions of fall

2018-06-26 theedgemarkets
(June 26): Philippine shares closed higher for the first time in nine sessions on Tuesday, driven mainly by industrial and real estate stocks, while Indonesian shares fell for a fifth session in six.
SMPH JGSMY JGS SPHXY SPHXF SPHZF JGSHF

14
Most rise; Philippines rebounds after 7 losing sessions

2018-06-25 theedgemarkets
(June 25): Most Southeast Asian stock markets rose on Monday, with the Philippines bouncing back after a seven-session losing streak, while Singapore fell to its lowest in more than eight-and-a-half months.
SMPH SMIVY SVTMF SPHXY SM SPHXF SPHZF O39

14
Most SE Asia stocks rise; Philippines rebounds after seven losing sessions

2018-06-25 malaymail
NEW YORK, June 25 — Most Southeast Asian stock markets rose today, with the Philippines bouncing back after a seven-session losing streak, while Singapore fell to its lowest in more than eight-and-a-half months.
SMPH SMIVY SVTMF SPHXY SM SPHXF SPHZF O39

36
Bargain hunters splurge as PSEi breaks 7,000 mark

2018-06-22 business.inquirer.net
The benchmark Philippine Stock Exchange index (PSEi) continued its descent on Friday, briefly dropping below the 7,000 level before bargain hunters entered the fray.
MER SVTMF PSKXF MPCIY BDOUY AYAAY JBFCY SM BDOUF SMPH BDO SMIVY JBFCF MPI MPCFF SPHXY JFC PHSXY PSE SPHXF SPHZF ALI AYAAF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...